Daryl Rebeck is a known personality in the business field particularly in medical and mining related businesses. With his appointment as the new president for LexaGene Holdings Inc. many individuals are wanting to know more about this prominent company’s new President.
First and foremost, Mr. Daryl Rebeck was born and raised in Canada and had attended the University of Manitoba, Red River College where he attained his Bachelor’s Degree in Business Administration. Shortly after graduation, he joined several small companies and eventually ended up with Canaccord Genuity Inc where he stayed for 14 years. He held the positions of Senior Investment Advisor and Vice President from December 1999 to November 2013. Being part of Canada’s largest independent full-service financial service firm gave him an edge and therefore becoming part of Cayden Resources as a consultant from November 2013 to September 2014 before the company was sold to Agnico Eagle Mining Limited for 205 million dollars in November of the same year. Finally, he joined Auryn Resources in November 2013 to January 2017 serving as its Senior Vice President for Corporate Finance before accepting the Presidency position for LexaGene in the same month.
He, however, is still with Auryn Services up to the present time, staying as their Advisor to Corporate Finance…
With his experiences in different fields, he gained a vast amount of knowledge and expertise in and out the medical field to equip him well as the new President of LexaGene. Being the former Vice President and Senior Investment Advisor for Canaccord Genuity, he was responsible in raising significant risk capital for different companies. During his stay, he particularly focused on medical technology and natural resources. This paved way for him in gaining background knowledge and expertise in the field. Furthermore, before accepting the post of President, he was also a director for LexaGene already. His outstanding performance and brilliance led him to being eventually offered the position.
With Mr. Daryl Rebeck taking post as President for LexaGene, we do expect to see more of the company’s growth in the coming years. LexaGene Holdings Inc is known to be one of the pioneers and leading companies in the field of biotechnology. They are focused in developing a fully automated pathogen detection platform featuring unprecedented sensitivity and speed. We are hoping that their aim in transforming multi-billion dollar markets like water quality monitoring, aquaculture pathogen surveillance and food safety in the prevention and diagnosis of diseases will finally come into fruition. The company’s CEO, Mr. Jack Regan is working hand in hand with its new President in reaching their goals. With both their efforts and dedication, we should expect great things from them.